Search

Etiology-Phenotype-Outcome Pathway Study on Freezing of Gait (FOG)

Trial N/A Recruiting March 9, 2026

Empowering Patients: The Role of Group Health Coaching in Improving Self-Efficacy and Well-Being in Parkinson's Disease.

Research American journal of lifestyle medicine March 9, 2026

Quercetin prevents age-related hearing loss in C57BL/6J mice by activating mitophagy and inhibiting the NLRP3 inflammasome.

Research PloS one March 9, 2026

Exercise for Cognitive Excellence in Parkinson's Disease

Trial N/A Recruiting March 8, 2026

RAD 1601: EDGE Radiosurgery for Intractable Essential Tremor and Tremor-Dominant Parkinson's Disease

Trial N/A Active, not recruiting March 8, 2026

Investigating the Cholinergic Contribution to Gait Dysfunction in Parkinson's Disease

Trial Phase 2 Completed March 8, 2026

Investigating Subcortical Contributions to Speech Sequencing in Deep Brain Stimulator Recipients

Trial N/A Recruiting March 8, 2026

Comparison of Different Rehabilitation Protocols in Parkinson's Disease With Postural Instability and Gait Disorders

Trial N/A Active, not recruiting March 8, 2026

What’s the Buzz with Beechband?

News Parking Suns March 8, 2026

Parkinson’s Perspectives: Living with Young Onset Parkinson’s

News A Closer Look Archives | American Parkinson Disease Association March 6, 2026

Plant natural products targeting NLRP3 inflammasome in Parkinson's disease: Molecular activation and regulation to therapeutics.

Research iScience March 6, 2026

Elucidating the Role of Cholinergic Degeneration in Cognitive Fluctuations in Lewy Body Dementia

Trial Phase 4 Recruiting March 5, 2026

Study of Sleep Disorders in Prodromal and Definite Parkinsons Disease

Trial N/A Recruiting March 5, 2026

Community Outreach for Palliative Engagement -- Parkinson Disease

Trial N/A Active, not recruiting March 5, 2026

Metaverse Applications in Clinical Neurorehabiliation: Device Feasibility

Trial N/A Active, not recruiting March 5, 2026

Lu AF28996 in Participants With Parkinson's Disease (PD)

Trial Phase 1 Completed March 5, 2026

[18F] - FD17 PET Imaging of α-synuclein: A Clinical Study in α-synucleinopathy Patients

Trial N/A Completed March 4, 2026

Gamma Sensory Flicker for Parkinson's Disease Patients With Freezing of Gait

Trial N/A Active, not recruiting March 4, 2026

Light Therapy for PD - Dose Selection

Trial N/A Completed March 4, 2026

Shanghai Clinical Cohort - Parkinson's Disease (Reserve)

Trial N/A Recruiting March 4, 2026